文献速递消化道肿瘤与早癌消化内镜

内镜黏膜下剥离术后异时性癌发生率:未分化型与分化型早期胃癌的比较

Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancer.
PubMed 文献 · Gastrointest Endosc · 2020-07-02

本研究纳入175例未分化型早期胃癌和随机选取的350例分化型早期胃癌患者,均接受内镜黏膜下剥离术并每年复查内镜。未分化型组异时性癌年发生率为0.9%,分化型组为5.3%;所有异时性癌均发生于幽门螺杆菌感染者,未分化型组异时性癌再行内镜黏膜下剥离术的治愈性切除率显著更低。

要点

  • 未分化型早期胃癌内镜黏膜下剥离术后异时性癌年发生率为0.9%,分化型为5.3%。
  • 所有异时性癌均发生于幽门螺杆菌感染患者。
  • 未分化型组异时性癌再行内镜黏膜下剥离术的治愈性切除率显著低于分化型组。

核心结论

  • 本队列中异时性癌仅发生于幽门螺杆菌感染患者。
  • 未分化型早期胃癌内镜黏膜下剥离术后异时性癌发生率显著低于分化型,但再行内镜黏膜下剥离术的治愈性切除率显著更低。
  • 作者建议未分化型早期胃癌内镜黏膜下剥离术后应更仔细地进行常规监测,尤其是幽门螺杆菌感染患者。

研究设计与样本

  • 纳入175例因未分化型早期胃癌接受内镜黏膜下剥离术的患者。
  • 同期随机选取350例因分化型早期胃癌接受内镜黏膜下剥离术的患者作为对照。
  • 患者每年接受内镜随访,中位观察期分别为6.0年和5.4年。

主要发现

  • 未分化型组异时性癌年发生率为0.9%,分化型组为5.3%。
  • 未分化型组中30.9%的患者未感染幽门螺杆菌,而分化型组所有患者均感染幽门螺杆菌。
  • 所有发生异时性癌的患者均感染幽门螺杆菌。
  • 未分化型组异时性癌再行内镜黏膜下剥离术的治愈性切除率显著低于分化型组。

临床怎么用

  • 作者建议未分化型早期胃癌内镜黏膜下剥离术后应更仔细地进行常规监测,尤其是幽门螺杆菌感染患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) has become an important and minimally invasive treatment for early gastric cancer (EGC) with a negligible risk of metastasis not only for differentiated-type (D-type) cancer but also for undifferentiated-type (UD-type) cancer. We aimed to investigate the incidence and characteristics of metachronous cancer after ESD for UD-type cancer, which has not yet been elucidated. METHODS: In total, 175 patients who underwent ESD for UD-type EGC were enrolled. For comparison, 350 patients who underwent ESD for D-type EGC during the same period were randomly selected. These patients underwent a follow-up EGD annually. The median observation period was 6.0 years and 5.4 years, respectively. RESULTS: The annual incidence of metachronous cancer after ESD for UD-type and D-type cancer was .9% and 5.3%, respectively. Among the patients who underwent ESD for UD-type cancer, 30.9% of patients were uninfected with Helicobacter pylori, whereas all patients who underwent ESD for D-type cancer were infected with H pylori. All patients who developed metachronous cancer were infected with H pylori. UD-type metachronous cancer developed more frequently in patients after ESD for UD-type cancer than after ESD for D-type cancer, and the curative resection rate of ESD was significantly lower in these cases. CONCLUSIONS: Metachronous cancers developed only in H pylori-infected patients in this cohort. Although metachronous cancer incidence was significantly less frequent in patients after ESD for UD-type cancer, the curative resection rate of ESD was significantly lower. Routine surveillance should be conducted more carefully after ESD for UD-type cancer, especially in H pylori-infected patients.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ishioka M, Yoshio T, Miyamoto Y, et al. Incidence of metachronous cancer after endoscopic submucosal dissection: a comparison between undifferentiated-type and differentiated-type early gastric cancer. Gastrointest Endosc. 2020. PMID: 32621817. doi:10.1016/j.gie.2020.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。